Total medical devices industry M&A deals in May 2019 worth $7.7bn were announced globally, according to GlobalData’s deals database.
Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 1482.7% over the previous month and a rise of 174.3% when compared with the last 12-month average, which stood at $2.81bn.
Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $7.29bn. At the country level, the US topped the list in terms of deal value at $7.29bn.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Asia-Pacific and then Europe.
The top country in terms of M&A deals activity in May 2019 was the US with 18 deals, followed by Japan with two and the UK with one.
In 2019, as of the end of May 2019, medical devices M&A deals worth $16.42bn were announced globally, marking an increase of 96.5% year on year.
Medical devices industry M&A deals in May 2019: Top deals
The top five medical devices industry M&A deals accounted for 99.9% of the overall value during May 2019.
The combined value of the top five medical devices industry M&A deals stood at $7.69bn, against the overall value of $7.7bn recorded for the month. The top announced medical devices industry M&A deal tracked by GlobalData in May 2019 was 3M’s $6.73bn acquisition of Acelity.
In second place was the $465m acquisition of VertiFlex by Boston Scientific and in third place was Ethicon US’s $400m asset transaction with Takeda Pharmaceutical.
The $97m acquisition of Soluble Systems by Misonix and WELL Health Technologies’ acquisition of KAI Innovations for $7.96m held fourth and fifth positions, respectively.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.